The six genome-wide association studies (GWAS) completed in bipolar disorder (BD) [1] [2] [3] [4] [5] [6] have revealed some promising association signals that have been replicated in independent study samples, 7 but the mechanism by which these genes increase disease susceptibility has remained unresolved. Here, our goal was (i) to replicate the best results from the study by Sklar et al., 2008 4 and also the highest ranking imputed SNPs from the WTCCC study 1 and (ii) to define the effect of the Figure 1 Elevated S100B serum concentrations (a) and an increased C-peptide/glucose ratio (b), indicating insulin resistance, were schizophrenia related. Increased BMI was primarily a consequence of antipsychotic medication and not a source of elevated S100B (c). Data are given as means with 95% confidence intervals. Only P-values of significant group differences are displayed. and were able to replicate associations with DFNBP31, SORCS2 and SLC39A3 genes. 7 In this study, we analyzed 50 new variants chosen from WTCCC and the study by Sklar et al. 1, 4 against diagnostic categories of bipolar type I disorder (BDI) and broad mood disorder. In addition, we studied the effect of 26 SNPs from our previous GWAS replication and of the 50 SNPs genotyped here, on 10 quantitative items (listed in Supplementary Table 1 ) of circadian preference for daily activities from the Horne-Ö stberg MorningnessEveningness Questionnaire, 8 on six items of seasonal variation in mood and behavior (global seasonality score) from the Seasonal Pattern Assessment Questionnaire 9 and on 22 neuropsychological test variables using the Wechsler Adult Intelligence Scale-Revised (WAIS-R), the Wechsler Memory Scale-Revised (WMS-R), the California Verbal Learning Test, the Stroop Color and Word Test and the Controlled Oral Word Association Test. Circadian and seasonality phenotypes were characterized from 127 individuals from 37 families, and neuropsychological phenotypes were characterized from 159 individuals from 65 families. Analyses of dichotomy phenotypes were carried out by FBAT (www.biostat.harvard.edu/~fbat) and those of quantitative phenotypes by QTDT, 10 analyzing affected and unaffected individuals together. Age, gender and affection status were used as covariates in QTDT analyses. SNP rs10982256 in DFNB31, which gave the strongest signal in our replication study, 7 associated also with four items of seasonality (strongest signal with the routine fluctuation in sleep duration across seasons; P = 0.005), as did two SNPs from the SORCS2 gene (P = 0.046) ( Table 1 ). In addition, one new variant from the WTCCC study, rs4027132 at 2p25.1, associated suggestively with bipolar type I disorder (P = 0.042).
Out of the newly genotyped variants from Sklar et al., 4 only those at the vicinity of the CDH7 gene (closest SNP being 250 kb upstream) and at high LD with each other, associated with bipolar type I disorder (Table 1) in our Finnish BD sample (P = 0.012-0.044 with seven different variants). Interestingly, these SNPs also associated with circadian rhythm and seasonality, as well as with visual attention and visual working memory, so that the disease-related allele of rs2850701 associated with increased seasonal variations in social activity and mood (P = 0.017 and 0.028, respectively), as well as with increased visual alertness reflected by an improved performance in visual attention (P = 0.006).
The CDH7 gene belongs to the cadherin superfamily. These transmembrane glycoproteins regulate, for example, brain development in several ways by cell sorting, migration, axon outgrowth, etc, 11 and it Table 1 SNPs associating with bipolar type I disorder or with mood disorder (P < 0.05) and the P-values with detailed phenotypes of circadian clockwork, seasonal variation, and neuropsychological traits giving P-values < 0.05 Reported in previous replication study. 7 Significant P-values ( < 0.05) in bold.
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